PRNewsWire
09 Nov 2026, 08:32 UTC · 6h ago
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law
Impact · against what's priced in
The news is catastrophic for TENX due to the failure of its lead candidate and subsequent legal investigation, while it is entirely irrelevant for LULU and BAC. The latter two are mentioned only as boilerplate reminders of unrelated existing lawsuits by the law firm.
- BAC+0.00
Doesn't touch the price's assumptions
- In context
The reference to a lawsuit is boilerplate marketing and does not impact the company's revenue growth or free-cash-flow margin projections.





